CBSH
Commerce Bancshares, Inc.52.89
-0.65-1.21%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
7.35BP/E (TTM)
13.26Basic EPS (TTM)
3.99Dividend Yield
0.02%Recent Filings
8-K
8-K
Board appointment and buyback approval
Commerce Bancshares appointed Alaina G. Maciá, CEO of MTM Health, as an independent board director effective October 31, 2025, filling the vacancy from Jonathan M. Kemper's retirement and joining the Compensation and Human Resources Committee until 2027. Her expertise in scaling a healthcare transportation firm from $30 million to nearly $2 billion in revenue bolsters the board's strategic oversight. On November 3, the board approved repurchasing up to 5 million common shares, combining with prior authorization, at management's discretion amid market conditions. This signals confidence in capital allocation. Yet risks could alter outcomes.
8-K
Q3 earnings up to $1.06/share
Commerce Bancshares reported third-quarter 2025 earnings of $1.06 per diluted share, up from $1.01 a year ago, with net income hitting $141.5 million on steady $17.5 billion average loans and robust $161.5 million non-interest income, fueled by 6.8% trust fee growth. While net interest income dipped slightly to $279.5 million amid a dynamic rate environment, credit quality shone with non-accrual loans at just 0.09% and a beefed-up $175.7 million allowance. The FineMark acquisition closes January 1, 2026, expanding into Florida and beyond. Solid returns persist.
8-K
Board member retires per policy
Commerce Bancshares' board saw Jonathan M. Kemper retire effective August 31, 2025, after 28 years of service since 1997, triggered by the company's mandatory retirement policy. As retired Chairman Emeritus of Commerce Bank, his departure marks a routine governance shift. No successor named yet. This change maintains board continuity amid stable operations.
10-Q
Q2 FY2025 results
Commerce Bancshares posted solid Q2 FY2025 results, with net income up 9.3% year-over-year to $152.5 million and diluted EPS rising 10.7% to $1.14, driven by net interest income growth of 6.8% to $280.1 million (derived) on higher investment yields and lower deposit costs, while non-interest income climbed 8.8% on trust and capital market fees. Gross margin isn't applicable, but operating income before taxes increased 8.9% to $196.2 million, reflecting controlled expenses up just 5.3%. Year-to-date, net income rose 12.6% to $284.1 million with EPS at $2.12, up 14.6%; free cash flow isn't disclosed in the 10-Q. Liquidity strengthened with $3.1 billion in cash equivalents and $6.3 billion in borrowing capacity, while total debt stood at $2.6 billion, mostly short-term. The pending FineMark acquisition, valued at $585 million in stock, eyes January 2026 close for geographic expansion. Yet regulatory hurdles in banking persist as a key risk.
IPO
Website
Employees
Sector
Industry
CBFV
CB Financial Services, Inc.
36.51+0.12
CBKM
Consumers Bancorp, Inc.
23.80-0.20
CFBK
CF Bankshares Inc.
24.36+0.43
EQBK
Equity Bancshares, Inc.
47.20+0.21
FMBH
First Mid Bancshares, Inc.
42.28-0.01
HBAN
Huntington Bancshares Incorpora
17.63-0.11
HWBK
Hawthorn Bancshares, Inc.
35.11+0.07
NKSH
National Bankshares, Inc.
33.71+0.29
NWBI
Northwest Bancshares, Inc.
12.71-0.07
TCBI
Texas Capital Bancshares, Inc.
94.72-1.38